Coherus Oncology, Inc. Balance Sheet
CHRS|6 years of annual SEC 10-K data (FY2014-FY2019)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 6 fiscal years. All figures from audited SEC 10-K filings.
Coherus Oncology, Inc. had $409M in total assets and $105M in shareholders' equity as of FY2019.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -0.49 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $177.7M | $72.4M | $126.9M | $150.4M | $39.6M | $14.5M |
| Accounts Receivable | - | - | - | $1.9M | $1.6M | $2.4M |
| Inventory | $9.8M | $1.7M | - | - | - | - |
| Current Assets | $343.0M | $84.4M | $145.5M | $161.5M | $197.4M | $179.1M |
| PP&E (Net) | $5.8M | $6.7M | $12.8M | $10.8M | $10.5M | $4.5M |
| Goodwill | $943.0K | $943.0K | $943.0K | $943.0K | $943.0K | $943.0K |
| Total Assets | $408.9M | $99.5M | $162.6M | $178.5M | $212.4M | $187.2M |
| Current Liabilities | $115.0M | $33.3M | $28.4M | $56.4M | $106.0M | $51.8M |
| Shareholders' Equity | $105.2M | -$38.6M | $30.5M | $20.5M | -$6.2M | $66.8M |